ITRM20050367A1 - Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea. - Google Patents

Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea.

Info

Publication number
ITRM20050367A1
ITRM20050367A1 IT000367A ITRM20050367A ITRM20050367A1 IT RM20050367 A1 ITRM20050367 A1 IT RM20050367A1 IT 000367 A IT000367 A IT 000367A IT RM20050367 A ITRM20050367 A IT RM20050367A IT RM20050367 A1 ITRM20050367 A1 IT RM20050367A1
Authority
IT
Italy
Prior art keywords
vegf
reconstruction
active fragments
functionally active
bone repair
Prior art date
Application number
IT000367A
Other languages
English (en)
Inventor
Salvatore Oliviero
Maurizio Orlandini
Adriano Spreafico
Original Assignee
Univ Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Siena filed Critical Univ Siena
Priority to IT000367A priority Critical patent/ITRM20050367A1/it
Priority to PCT/IT2006/000433 priority patent/WO2007007362A2/en
Priority to US11/993,825 priority patent/US20090214495A1/en
Priority to AU2006267819A priority patent/AU2006267819A1/en
Priority to EP06766317A priority patent/EP1915392A2/en
Publication of ITRM20050367A1 publication Critical patent/ITRM20050367A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1858Platelet-derived growth factor [PDGF]
    • A61K38/1866Vascular endothelial growth factor [VEGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1841Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1875Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IT000367A 2005-07-08 2005-07-08 Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea. ITRM20050367A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT000367A ITRM20050367A1 (it) 2005-07-08 2005-07-08 Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea.
PCT/IT2006/000433 WO2007007362A2 (en) 2005-07-08 2006-06-09 Vegf-d and functional fragments thereof for bone repair
US11/993,825 US20090214495A1 (en) 2005-07-08 2006-06-09 Vascular endothelial growth factor-d (vegf)-d and functionally fragments thereof for bone repairing
AU2006267819A AU2006267819A1 (en) 2005-07-08 2006-06-09 VEGF-D and functional fragments thereof for bone repair
EP06766317A EP1915392A2 (en) 2005-07-08 2006-06-09 Vegf-d and functional fragments thereof for bone repair

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000367A ITRM20050367A1 (it) 2005-07-08 2005-07-08 Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea.

Publications (1)

Publication Number Publication Date
ITRM20050367A1 true ITRM20050367A1 (it) 2007-01-09

Family

ID=37602949

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000367A ITRM20050367A1 (it) 2005-07-08 2005-07-08 Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea.

Country Status (5)

Country Link
US (1) US20090214495A1 (it)
EP (1) EP1915392A2 (it)
AU (1) AU2006267819A1 (it)
IT (1) ITRM20050367A1 (it)
WO (1) WO2007007362A2 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3773677B1 (en) * 2018-04-12 2025-04-02 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Anti-aging compositions and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5942496A (en) * 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
ES2239338T5 (es) * 1995-09-29 2013-05-31 Vegenics Pty Ltd Genes regulados y sus usos
WO2005030240A2 (en) * 2003-09-23 2005-04-07 Ludwig Institute For Cancer Research Vege-cor vege-d materials and methods for stimulation of neural stem cells
US20050043235A1 (en) * 2003-06-12 2005-02-24 Kari Alitalo Use of VEGF-C or VEGF-D in reconstructive surgery
US20060039949A1 (en) * 2004-08-20 2006-02-23 Nycz Jeffrey H Acetabular cup with controlled release of an osteoinductive formulation

Also Published As

Publication number Publication date
AU2006267819A1 (en) 2007-01-18
WO2007007362A3 (en) 2007-06-28
EP1915392A2 (en) 2008-04-30
WO2007007362A2 (en) 2007-01-18
US20090214495A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
BRPI0911203A2 (pt) peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo.
LTC2100614I2 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
BRPI0717219A2 (pt) "composição imunogênica, método para tratar ou prevenir doença, e, uso de uma composição imunogênica."
BRPI0907663A2 (pt) ''composição que compreende hfo- 123 yf, composição que compreende hcfc-243db, composição que compreende hcfo- 1233xf, composição que comproeende hcfc- 244bb, uso das composições e método de uso das composições.
BRPI0920111A2 (pt) dispositivo corrediço unidirecional para implantes de fixação intramedulares e intertrocantéricos.
FR2884136B1 (fr) Implant chirurgical intervertebral formant rotule
MEP59208A (en) Activin-actriia antagonists and uses for promoting bone growth
BRPI0619585A2 (pt) aparelho para aumento osteopático
FR2935601B1 (fr) Implant intramedullaire resorbable entre deux os ou deux fragments osseux
CL2007002642A1 (es) Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer.
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
DE602006003922D1 (de) Chirurgisches Implantat
EP1854415A4 (en) SURGICAL TREATMENT DEVICE
BRPI0813563A2 (pt) Implante de tecido ósseo compreendendo íons de estrôncio
EP1863899A4 (en) COMPOSITIONS FOR TREATING SKIN
DK1827412T3 (da) Sammensætninger til anvendelse i kirurgi
EP1917978A4 (en) MEANS OF PREVENTING PREVIOUS OVULATION
IT1391866B1 (it) Composizione iniettabile di polinucleotidi per il trattamento di patologie osteoarticolari.
BRPI0815768A2 (pt) Uso de absorventes de uv, e, composição cosmética.
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
CL2007002769A1 (es) Compuestos derivados de sulfonamida; procedimiento de obtencion; composicion farmaceutica; y uso en el tratamiento de la diabetes.
PT2056805E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de reacção tecidular
BRPI0615630A2 (pt) composição farmacêutica, e, uso de sertindol
ITRM20050367A1 (it) Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea.
ITRM20060688A1 (it) 2-6-difenil-4,8diazoadamantan-1-one e suoi derivati suo procedimento di preparazione e suo uso per la formulazione di soluzioni ad azione sterilizzante e disinfettante